Q14289 (FAK2_HUMAN) Homo sapiens (Human)
Protein-tyrosine kinase 2-beta UniProtKBInterProSTRINGInteractive Modelling
1009 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
26 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of the Focal Adhesion Targeting (FAT) Domain of Pyk2 in Complex with Paxillin LD4… |
Heteromer P49023; | 99.29 | ||||
| Pyk2-FAT domain in complex with leupaxin LD4 motif |
Heteromer O60711; | 98.52 | ||||
| Pyk2-FAT complexed with Leupaxin LD motif LD1 |
Heteromer O60711; | 98.52 | ||||
| Fusion of Pyk2-FAT domain with Leupaxin LD1 motif, complexed with Leupaxin LD4 peptide |
Heteromer O60711; | 98.51 | ||||
| Crystal Structure Analysis of Pyk2 and Paxillin LD motifs |
Heteromer P49024; | 98.48 | ||||
| Structural basis for the interaction of Pyk2 PAT domain with paxillin LD motifs |
Heteromer P49023; | 99.23 | ||||
| Structure of the murine cortactin C-SH3 domain in complex with a Pyk2 proline-rich ligand |
Heteromer Q60598; | 100 | ||||
| 3D domain-swapped dimer of the maltose-binding protein fused to a fragment of the protein-tyrosine … | homo-2-mer | 100 | 2×GLC; | |||
| Crystal Structure of FERM Domain of Proline-rich Tyrosine Kinase 2 | monomer | 100 | ||||
| Crystal structure of kinase domain of protein tyrosine kinase 2 beta (PTK2B) | monomer | 100.0 | 1×MG; 1×GOL; | |||
| Crystal structure of PYK2 in complex with Sulfoximine-substituted trifluoromethylpyrimidine analog | monomer | 100.0 | 5×SO4; 1×P1E; | |||
| The Crystal Structure of FAK2 from Biortus. | monomer | 100.0 | 1×YAM; 3×EDO; | |||
| Crystal structure of PYK2 complexed with ATPgS | monomer | 100.0 | 1×AGS; 2×SO4; | |||
| Crystal structure of PYK2 complexed with PF-2318841 | monomer | 100.0 | 1×349; 1×PO4; | |||
| Crystal structure of PYK2 complexed with PF-431396 | monomer | 100.0 | 1×3JZ; 1×PO4; | |||
| Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency | monomer | 100.0 | 1×7FM; | |||
| Crystal structure of PYK2 with the pyrazole 13a | monomer | 100.0 | 1×0YH; | |||
| Structure of the PYK2 from Biortus. | monomer | 100.0 | ||||
| Crystal Structure of PYK2-Apo, Proline-rich Tyrosine Kinase | monomer | 100.0 | ||||
| Crystal Structure of PYK2 complexed with BIRB796 | monomer | 100.0 | 1×B96; | |||
| Crystal structure of PYK2 complexed with PF-4618433 | monomer | 100.0 | 1×4JZ; | |||
| Crystal structure of PYK2 with the indole 10c | monomer | 100.0 | 1×0YJ; | |||
| Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency | monomer | 100.0 | 1×YAM; | |||
| Structural and mechanistic insights into the interaction between PAT Pyk2 and Paxillin LD motif | monomer | 98.52 | ||||
| Crystal Structure of the Focal Adhesion Targeting (FAT) Domain of Pyk2 | monomer | 99.25 | ||||
| Crystal Structure of the Focal Adhesion Targeting (FAT) Domain of Pyk2 | monomer | 99.21 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2j0j.1.A | monomer | 0.70 | 52.49 | |||
| 6ty3.1.A | monomer | 0.64 | 52.34 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 2j0j.1.A | monomer | 0.70 | 52.49 | |||
| Isoform 2 | 6ty3.1.A | monomer | 0.65 | 52.34 | |||